Brett King, MD, PhD
Associate Professor of Dermatology
Yale School of Medicine
Disclosure
Advisory Board/Consultant: Abbvie, AltruBio Inc, Almirall, Amgen, AnaptysBio, Apogee Therapeutics, Arena Pharmaceuticals, Aslan Pharmaceuticals, Bristol Meyers Squibb, Concert Pharmaceuticals Inc, Equillium, Horizon Therapeutics, Eli Lilly and Company, Incyte Corp, Janssen Pharmaceuticals, LEO Pharma, Merck, Otsuka/Visterra Inc, Pfizer Inc, Q32 Bio Inc, Regeneron, Sanofi Genzyme, Sun Pharmaceutical Industries, Takeda, TWi Biotechnology Inc
Other Relationships: SAB – BiologicsMD
Data Monitoring Committee for Incyte Corp, Ventyx Biosciences Inc, Clinical trial investigator for AnaptysBio, Arena Pharmaceuticals, Aslan Pharmaceuticals, Bristol Meyers Squibb, Concert Pharmaceuticals Inc, Eli Lilly and Company, NIH, Pfizer Inc